Abstract: A vehicle may include a side mirror including a housing and a mirror member provided inside the housing and rotatable in a first axis and a second axis in the housing; an input unit configured to receive an identification information related to a driver; a driving apparatus configured to identify a target position corresponding to the identification information related to the driver, acquire a plurality of paths for moving the mirror member between the identified target position and the current position, identify each of positions for switching the movement direction of the acquired plurality of paths, select a path having positions for switching the movement direction closest to a predetermined center position among the respective positions for switching the movement direction thereof, and selectively control rotation of the first axis and rotation of the second axis of the mirror member based on the selected path.

Abstract: The present disclosure relates to methods of treating a cancer (or a tumor) with an IL-7 protein in combination with an immune checkpoint inhibitor, such as a PD-1 antagonist (e.g., anti-PD-1 antibody) or a CTLA-4 antagonist (e.g., anti-CTLA-4 antibody).

Abstract: Disclosed are methods, systems, devices, apparatus, media, design structures, and other implementations, including a method that includes receiving, at a local device from a remote device, query data representative of a question relating to source content of a source document of a repository of a plurality of source documents, with the source content being associated with transformed content accessible from the local device. The method further includes generating, in response to determination, at the local device, of a match between the query data and at least one portion of the transformed content, output data comprising one or more of a pointer to access, in the source document accessible from the remote device, at least one portion of the source document corresponding to the at least one portion of the transformed content, or a copy of the at least one portion of the source document.

Abstract: Disclosed are methods, systems, devices, apparatus, media, design structures, and other implementations, including a method that includes receiving a source document, applying one or more pre-processes to the source document to produce contextual information representative of the structure and content of the source document, and transforming the source document, based on the contextual information, to generate a question-and-answer searchable document.

Abstract: A treatment of cervical tumor caused by human papillomavirus (HPV) infection is disclosed. Methods for improving cervical tumor treatment and methods for treating cervical tumor caused by HPV infection include administering a combination of a HPV-specific fusion protein and an immunomodulatory agent.

Abstract: Provided are a modified IL-7 polypeptide and a fusion protein containing the modified IL-7 polypeptide. The fusion protein of the modified IL-7 includes: a first domain containing an interleukin-7 polypeptide; a second domain containing an oligopeptide having 1 to 10 amino acid residues (with proviso that the second domain excludes the oligopeptide consisting of methionine and/or glycine); and (c) a third domain which prolongs the half-life of the IL-7 fusion protein. The modified IL-7 polypeptide is composed of the (a) first domain and the (b) second domain. The modified IL-7 polypeptide and the fusion protein are expressed in a higher yield than the wild-type IL-7 and shows increased stability.

Abstract: Embodiments of the present disclosure relate to a memory system, a memory controller, and a method for operating a memory system. According to embodiments of the present disclosure, a memory system may configure first peak power management information for controlling the plurality of memory dies, may determine, when an error occurs while controlling a plurality of memory dies, new peak power management information corresponding to operation information and environment information at the time at which the error occurs, respectively, and may change from the first peak power management information to the second peak power management information according to subsequent operation information and environment information. Accordingly, the memory system is capable of minimizing the possibility of occurrence of errors in a read, write, or erase operation and increasing the stability of an operation for transmitting and receiving commands or data to and from the host.

Abstract: A semiconductor device includes a substrate, a first recess formed in the substrate, a first source/drain filling the first recess, a vertical metal resistor on the first source/drain, and an insulating liner separating the metal resistor from the first source/drain, with the vertical metal resistor being between two gate electrodes.

Abstract: The present invention relates to; a recombinant lentivirus comprising a gene encoding brain-derived neurotrophic factor (BDNF) protein; and a mesenchymal stem cell transformed with the lentivirus; and a method for mass-producing a cell therapeutic agent expressing BDNF protein using the same. The mesenchymal stem cell transformed with the recombinant lentivirus of the present invention can regulate the timing of expression of BDNF protein, maintain a high cell proliferation rate and overexpress a BDNF protein, and are excellent in safety. Therefore, a mesenchymal stem cells transfected with the lentivirus may be used for the treatment of various neurological diseases as a stein cell therapeutic agent capable of being mass-produced and maintaining the same effect.

Abstract: The present invention relates to a composition for the diagnosis and treatment of recurrent thyroid cancer comprising recombinant human thyroid stimulating hormone (rhTSH) and a method for producing the recombinant human thyroid hormone. The method for producing recombinant human thyroid hormone according to the present invention can effectively produce rhTSH despite being cultured through fed-batch culture, and has a high purification yield and purity. Therefore, the recombinant thyroid stimulating hormone produced by the method can be usefully used for the diagnosis or treatment of recurrent thyroid cancer.

Abstract: A gate all around field effect transistor (GAAFET) device may include a plurality of nanostructures that are spaced apart from one another in a channel region of the FET device above a substrate. A gate electrode can be in a GAA arrangement with the plurality of nanostructures and a semiconductor pattern can be on one side of the gate electrode. A contact in a contact trench in the semiconductor pattern and a silicide film can extend conformally on a side wall of the contact trench to a level in the channel region that is lower an uppermost one of the plurality of nanostructures.

Abstract: In one example embodiment, a semiconductor system includes a first chip configured to generate first temperature information of the first chip, the first temperature information being based on at least one temperature measurement using at least one first temperature sensor. The semiconductor system further includes a second chip including a second temperature sensor configured to be controlled based on at least the first temperature information.

Abstract: The present invention provides a polypeptide dimeric protein containing two monomers, each of which contains an extracellular domain (Fc?RIa-ECD) of an alpha subunit of an IgE Fc receptor. The dimeric protein according to the present invention has advantages that an excellent binding ability to IgE is exhibited as compared with a conventional therapeutic agent containing an anti-IgE antibody, and less other side effects are exhibited due to lack of ADCC and CDC functions. Thus, the dimeric protein can be applied to a medical product for treating or preventing an IgE-mediated allergic disease.

Abstract: An artificial intelligence system monitors and records usage of a set of mobile devices that have been “paired” or grouped together. The system, over time, accumulates a history of times and locations associated with events that occur with respect to the devices. From this history, the system develops a usage model for the devices. The system, if it detects current usage diverges significantly from an expected usage, performs responsive actions which may include: notifying a user, via a paired device, that the mobile device may be lost or misplaced; command the “lost” mobile device to enter a reduced power state, to prolong battery life; and/or command the “lost” device to emit audible and/or visible signals intended to facilitate locating the device. In some embodiments, the system predicts an imminent loss of the device before it becomes lost, based on current usage vs. expected usage embodied in the model.

Abstract: A method of forming a semiconductor device can be provided by forming an opening that exposes a surface of an elevated source/drain region. The size of the opening can be reduced and a pre-amorphization implant (PAI) can be performed into the elevated source/drain region, through the opening, to form an amorphized portion of the elevated source/drain region. A metal-silicide can be formed from a metal and the amorphized portion.

Abstract: An approach is provided for determining a product value score. Features of a product are identified. Ranking data for each identified feature is collected. The ranking data includes popularity, stability, availability, and memory usage of each feature. Additional data for each feature are determined. The additional data includes an importance, a conversion rate, and a marketing impact of each feature. Based on the ranking data and the additional data, normalized data is generated according to characteristics of the features. Based on a data science prediction analysis which uses the identified features, weights of the features are determined. Based on initial results of the data science prediction analysis, a key product is selected from a set of products. Based on the key product and the weights, product value scores of products in the set of products are determined.

Abstract: A gate all around field effect transistor (GAAFET) device may include a plurality of nanostructures that are spaced apart from one another in a channel region of the FET device above a substrate. A gate electrode can be in a GAA arrangement with the plurality of nanostructures and a semiconductor pattern can be on one side of the gate electrode. A contact in a contact trench in the semiconductor pattern and a silicide film can extend conformally on a side wall of the contact trench to a level in the channel region that is lower an uppermost one of the plurality of nanostructures.

Abstract: Methods and systems of classifying suspicious users are described. A processor may determine whether a domain name, of an email address of a user that requested to access a network, is valid. The processor may classify the user as a suspicious user if the domain name is invalid. If the domain name is valid, the processor may determine a likelihood that the email address is a script-generated email address. The processor may classify the user as a suspicious user if the email address is likely to be a script-generated email address. If the email address is unlikely to be a script-generated email address, the processor may identify abnormal usage behavior exhibited by the user based on a reference model. The processor may classify the user as a suspicious user if abnormal usage behavior is identified, and may reject a subsequent request from the user to access the network.

Abstract: A method of regulating blood glucose level and/or treating a diabetes is disclosed. The method includes administering a fusion peptide of a GLP-1 peptide and an Fc region. The Fc region is a hybrid Fc region containing a hinge region, a CH2 domain, and a CH3 domain from the N-terminal to the C-terminal direction, wherein the hinge region comprises a human IgD hinge region, the CH2 domain comprises a part of the amino acid residues of CH2 domain of human IgD and human IgG4, and the CH3 domain comprises a part of the amino acid residues of the human IgG4 CH3 domain, and has glycosylation at the IgD hinge region. The fusion peptide shows reduced side effects such as vomiting, nausea, and/or heart rate increase.

Abstract: Disclosed are a method for manufacturing a lithium secondary battery positive active material exhibiting a concentration gradient and a lithium secondary battery positive active material exhibiting a concentration gradient, manufactured by the method, and more particularly, a method for manufacturing a lithium secondary battery positive active material exhibiting a concentration gradient and a lithium secondary battery positive active material exhibiting a concentration gradient, manufactured by the method, the method being characterized by forming a barrier layer so as to maintain a concentration gradient layer even in case of thermal diffusion by a subsequent thermal treatment process.